Bayer US head says FDA chief reassured pharma executives of timely reviews - Reuters
  Bayer to present updates on pharma growth strategy and pipeline advancements at J.P. Morgan’s 43rd Annual Healthcare Conference - Bayer
  As Bayer's restructuring rolls on, Kerendia and Nubeqa power pharma unit to surprising sales increase - Fierce Pharma
  EMA Committee recommends marketing nod for Bayer advanced prostate cancer drug darolutamide - Medical Dialogues
  Bayer Shares Jump After Results Beat Expectations on Pharma Strength - WSJ
  Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances - Business Wire
  2025 on track to become a Landmark Launch Year for Bayer Pharmaceuticals - FirstWord Pharma
  Bayer braces for ‘difficult’ year before turnaround pays dividends - BioPharma Dive